Patent · US Active

Antibodies and use thereof

US11208477B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Peter M. Tessier · Ann Arbor, US
Samuel D. Stimple · Boston, US
Arne Staby · Avenue Madeleine, DK

Key dates

Filing date	Mar 31, 2020
Grant date	Dec 28, 2021
Priority date	—
Expiry date	Mar 31, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.